← SynDRA
VS-5584
SynDRA canonical compound SYN0038132 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PIK3CG |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
- MTOR
- PIK3CG
- PIK3CA
- PIK3CB
- PIK3CD
- MAPKAP1
- MTOR-RPTORA-MLST8-KT1S1-DEPTOR
Mechanisms of action (all sources)
- MTOR inhibitor
- PI3K inhibitor
- Serine/threonine-protein kinase mTOR inhibitor
- PIK3CA INHIBITOR
- PIK3CB INHIBITOR
- PIK3CD INHIBITOR
- PIK3CG INHIBITOR
- MTOR MODULATOR
- PIK3CG MODULATOR
- Inhibitor
- MAPKAP1 INHIBITOR
Cross-references
Synonyms
- 5-(9-Isopropyl-8-methyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine
- VS-5584 (SB2343)
- UNII-W71J4X250V
- SB-2343
- SB2343
- CHEMBL3393066
- W71J4X250V
- 5-(8-methyl-2-morpholin-4-yl-9-propan-2-ylpurin-6-yl)pyrimidin-2-amine
- C17H22N8O
- QYBGBLQCOOISAR-UHFFFAOYSA-N
- SCHEMBL539098
- GTPL8382
- EX-A288
- DTXSID10677328
- MolPort-035-757-944
- HMS3652B16
- BCP08247
- 2797AH
- ZINC95644685
- s7016
- VS5584
- BDBM50059635
- AKOS024465057
- 5-(9-isopropyl-8-methyl-2-morpholin-4-yl-9H-purin-6-yl)-pyrimidin-2-ylamine
- SB16877
- RefChem:194645
- MFCD25372027
- orb1301070
- SCHEMBL29376859
- VS 5584 [WHO-DD]
- GLXC-90371
- NSC778810
- NSC800991
- CCG-268087
- CS-1202
- EBC-157243
- NSC-778810
- NSC-800991
Look up VS-5584 in the interactive SynDRA portal →